AU2017902645A0 - Dietary supplement for treatment of acute environmental inflammation - Google Patents

Dietary supplement for treatment of acute environmental inflammation

Info

Publication number
AU2017902645A0
AU2017902645A0 AU2017902645A AU2017902645A AU2017902645A0 AU 2017902645 A0 AU2017902645 A0 AU 2017902645A0 AU 2017902645 A AU2017902645 A AU 2017902645A AU 2017902645 A AU2017902645 A AU 2017902645A AU 2017902645 A0 AU2017902645 A0 AU 2017902645A0
Authority
AU
Australia
Prior art keywords
inflammation
treatment
dietary supplement
acute environmental
acute
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017902645A
Inventor
Malcolm BALL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GRATUK TECHNOLOGIES Pty Ltd
Original Assignee
GRATUK TECHNOLOGIES Pty Ltd
Filing date
Publication date
Application filed by GRATUK TECHNOLOGIES Pty Ltd filed Critical GRATUK TECHNOLOGIES Pty Ltd
Publication of AU2017902645A0 publication Critical patent/AU2017902645A0/en
Abandoned legal-status Critical Current

Links

AU2017902645A 2017-07-06 Dietary supplement for treatment of acute environmental inflammation Abandoned AU2017902645A0 (en)

Publications (1)

Publication Number Publication Date
AU2017902645A0 true AU2017902645A0 (en) 2017-07-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP3602384A4 (en) Layered masking of content
EP3731849A4 (en) Exosomes for immuno-oncology and anti-inflammatory therapy
EP3402517A4 (en) Immunologic treatment of cancer
EP3585389A4 (en) Treatment of egfr-driven cancer with fewer side effects
EP3635927A4 (en) Crest factor reduction
EP3576733A4 (en) Method of reducing neutropenia
EP3313395A4 (en) Method of treating inflammation using natural compounds and/or diet
EP3565539A4 (en) Medicinal compounds and nutritional supplements
EP3606663A4 (en) Methods and uses of encapsulated exudates and driedeuglena
EP3592731A4 (en) Inhibitors of malt1 and uses thereof
EP3558313A4 (en) Substances for treatment of fatty liver-related conditions
EP3663286A4 (en) Photosensitizer and derivatives and application thereof
EP3609500A4 (en) Treatment of adipocytes
EP3229813A4 (en) Treatment of hmgb1-mediated inflammation
EP3686204A4 (en) Thienodiazepine derivatives and application thereof
EP3654987A4 (en) Use of aminoalkylbenzothiazepine derivatives
EP3111939A4 (en) Vitamin d and antibacterial uses of composition thereof
EP3642415A4 (en) Nanolignocellulose compositions and processes to produce these compositions
EP3699550A4 (en) Reduction gear
EP3213769A4 (en) Transdermal-absorption-promoter and transdermal-absorption-promoting supplement
EP3684309A4 (en) Devices and methods for reducing cystine crystalsin vivo
EP3582770A4 (en) Formulations of cannabinoids for the treatment of acne
EP3541393A4 (en) Taste masking product
EP3575570A4 (en) Supercharger
GB201602804D0 (en) Dietary supplement